Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashir, R.
Right arrow Articles by Hochberg, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bashir, R.
Right arrow Articles by Hochberg, F. H.
NEUROLOGY 1996;46:440-444
© 1996 American Academy of Neurology

T-cell infiltration of primary CNS lymphoma

Rifaat Bashir, MD, Marc Chamberlain, MD, Elizabeth Ruby, MS and Fred H. Hochberg, MD

From the Division of Neurology (Dr Bashir), Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, UCSD Medical Center (Dr. Chamberlain), San Diego, CA; the Department of Preventive and Societal Medicine (E Ruby), University of Nebraska Medical Center, Omaha NE; and the Department of Neurology (Dr. Hochberg), Massachusetts General Hospital Boston, MA.
Presented in part at the 47th annual meeting of the American Academy of Neurology, Seattle, WA, May 1995.
Received March 27, 1995. Accepted in final form July 7, 1995.
Address correspondence and reprint requests to Dr. Rifaat Bashir, Chief, Division of Neurology, University of Nebraska Medical Center, 600 S 42nd St, Omaha, NE 68198-2045.

We stained 13 primary CNS lymphomas (PCNSLs) (six from patients with AIDS, seven from immunocompetent patients) with a panel of antibodies to T cells (pan T cell [CD3], T helper cell [CD4], T suppressor cell [CD8], delta/Delta cell [CD4minus 8minus]), B cells (CD20), hematopoietic cells (T200), and NK cell (CD56).We estimated the percentage of tumor cells staining with each antibody. All tumors were B-cell lymphomas. The non-AIDS tumors showed a significant infiltration with CD3plus cells (mean of 10.82% of total cells). The AIDS patients' tumors showed a smaller percentage of CD3plus infiltrating cells (mean, 4 88% of total cells) (p less than 0.01) CD4plus cells were 9.11% of the total hematopoietic cells in the non-AIDS patients and 3.13% in AIDS patients (p less than 0.01). AIDS patients showed some CD8plus cells (0.3%), which was significantly higher than in immunocompetent patients (0%) (p less than 0.05). Very few tumor cells stained with the NK cell and delta/Delta cell markers. Both immunocompetent and AIDS patients with PCNSL exhibit significant CD3plus and CD4plus cell infiltration of their tumors, this infiltration is significantly lower in AIDS patients. AIDS patients show a minor CD8plus cell infiltration of their tumors. These results on PCNSL are different from systemic lymphomas, which show a higher CD4 and CD8 cell infiltration, and may offer insights into the more aggressive nature of AIDS-related PCNSL.

NEUROLOGY 1996;46: 440-444




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
B. E. Wahlin, B. Sander, B. Christensson, and E. Kimby
CD8+ T-Cell Content in Diagnostic Lymph Nodes Measured by Flow Cytometry Is a Predictor of Survival in Follicular Lymphoma
Clin. Cancer Res., January 15, 2007; 13(2): 388 - 397.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. M. M. Gijtenbeek, M. K. Rosenblum, and L. M. DeAngelis
Primary central nervous system T-cell lymphoma
Neurology, August 28, 2001; 57(4): 716 - 718.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. M. Ansell, M. Stenson, T. M. Habermann, D. F. Jelinek, and T. E. Witzig
CD4+ T-Cell Immune Response to Large B-Cell Non-Hodgkin's Lymphoma Predicts Patient Outcome
J. Clin. Oncol., February 1, 2001; 19(3): 720 - 726.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T Kuhlmann, A Schroter, P Dechent, F Weber, H H Rustenbeck, L Fuzesi, W Bruck, H Ehrenreich, and J Frahm
Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy
J. Neurol. Neurosurg. Psychiatry, February 1, 2001; 70(2): 259 - 262.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
P. P. Molnar, B. P. O'Neill, B. W. Scheithauer, and D. R. Groothuis
The blood-brain barrier in primary CNS lymphomas: Ultrastructural evidence of endothelial cell death
Neuro-oncol, April 1, 1999; 1(2): 89 - 100.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by AAN Enterprises, Inc.